M. Grimley

发表

CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study

K. Myers, S. Davies, P. Mehta, 2020, Bone Marrow Transplantation.

Off the Shelf Third Party Virus Specific T-Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplant Recipients

P. Hanley, C. Bollard, J. Cancelas, 2021, Transplantation and Cellular Therapy.

Pediatric acute liver failure and immune dysregulation.

F. DiPaola, J. Bucuvalas, M. Grimley, 2014, The Journal of pediatrics.

Childhood pyelonephritis: comparison of gadolinium-enhanced MR imaging and renal cortical scintigraphy for diagnosis.

J. Morrison, T. Kao, G. Lonergan, 1998, Radiology.

Familial childhood leukemia cluster with multiple aggressive early-onset hematological malignancies

G. Tomlinson, D. Wall, M. Grimley, 2006, Leukemia & lymphoma.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

M. Norkin, S. Choi, M. Qayed, 2021, Blood advances.

Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.

S. Davies, A. Filipovich, J. Villanueva, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children.

S. Davies, S. Jodele, C. Dandoy, 2017, Blood.

E. Neufeld, F. Trachtenberg, A. Thompson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.

P. Hanley, C. Bollard, J. Cancelas, 2020, Blood advances.

Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry

K. Myers, S. Davies, J. Woods, 2019, European Respiratory Journal.

Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1 β inhibition

D. Lewis, R. Goldbach-Mansky, R. Bacchetta, 2021 .

Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series

Ranjit S. Chima, K. Myers, S. Davies, 2017, Bone Marrow Transplantation.

Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.

P. Hanley, C. Bollard, J. Cancelas, 2020, Blood advances.

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

A. Vinks, K. Myers, S. Davies, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The successful use of alemtuzumab for treatment of steroid‐refractory acute graft‐versus‐host disease in pediatric patients

K. Myers, S. Davies, P. Mehta, 2014, Pediatric transplantation.

Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant.

S. Davies, Ashish R. Kumar, Anthony Sabulski, 2020, Journal of clinical immunology.

D. Wall, K. Chan, K. Chan, 2008, Bone Marrow Transplantation.

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

K. Myers, S. Davies, S. Jodele, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

A. King, G. Cuvelier, N. Bunin, 2015, American journal of hematology.

Unique Challenges of Hematopoietic Stem Cell Transplant for Sickle Cell Disease

P. Khandelwal, M. Grimley, 2018 .

S. Spellman, J. Panepinto, B. Logan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients.

K. Myers, S. Davies, S. Jodele, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway

J. Casanova, A. Schulz, D. Jonigk, 2020, Cells.

Transplant Consortium study graft-versus-host disease in children: a Pediatric Blood and Marrow Evaluation of pentostatin in corticosteroid-refractory chronic

A. Rademaker, E. Nemecek, K. Schultz, 2013 .

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

A. Rademaker, E. Nemecek, L. Lehmann, 2009, Blood.

Bortezomib for refractory autoimmunity in pediatrics.

S. Davies, S. Jodele, A. Filipovich, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early identification and management of graft failure after unrelated cord blood transplantation

D. Wall, K. Chan, M. Grimley, 2008, Bone Marrow Transplantation.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

A. Fischer, A. Schulz, W. Friedrich, 2012, Blood.

Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells

E. Levy, D. Kleiner, A. Freeman, 2021, Frontiers in Immunology.

Short title: Outcome of related and unrelated HSCT for SCID

A. Fischer, A. Schulz, W. Friedrich, 2017 .

A. Fischer, A. Schulz, W. Friedrich, 2014 .

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

M. Norkin, S. Furlan, M. Pasquini, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

N. Callander, C. Freytes, P. Shaughnessy, 2004 .

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.

A. Sette, P. Hanley, C. Bollard, 2021, Blood advances.

Valganciclovir for the prophylaxis of cytomegalovirus infection early after allogenic stem cell transplantation

N. Callander, C. Freytes, P. Shaughnessy, 2011 .

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of Clinical Immunology.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

S. Davies, M. Jordan, Ashish R. Kumar, 2020, Journal of clinical immunology.

Graft Versus Host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta Thalassemia Major with Busulfan, Fludarabine, and Thiotepa.

S. Davies, C. Dandoy, P. Khandelwal, 2020, Transplantation.

CD38 bright CD8+ T-cells Associated with the Development of Acute GVHD are Activated, Proliferating, and Cytotoxic Trafficking Cells.

C. Lutzko, S. Davies, M. Jordan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful Treatment of Disseminated Adenovirus Infection in an Infant With Acute Lymphoblastic Leukemia

J. Mo, M. O'Brien, M. Grimley, 2015, Journal of pediatric hematology/oncology.

Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning

K. Myers, S. Davies, S. Jodele, 2018 .

Reduced Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplant: Gonadal Toxicity and Fertility Following Pediatric HSCT.

K. Myers, S. Jodele, C. Dandoy, 2022, Transplantation and cellular therapy.

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.

S. Grupp, K. Boucher, M. Pulsipher, 2009, Blood.

Post-Transplant CD34+ Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.

S. Davies, M. Jordan, P. Khandelwal, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe autoinflammation in four patients with C-terminal variants in CDC42 successfully treated with IL-1β inhibition.

D. Lewis, K. Jagadeesh, R. Laxer, 2019, The Journal of allergy and clinical immunology.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

J. Kurtzberg, J. Englund, Marion E. Morrison, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

F. Bushman, S. Witting, E. Grassman, 2018, Blood.

Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults

K. Myers, S. Davies, P. Mehta, 2021, Transplantation.

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.

R. Lorsbach, M. Wunderlich, Jason Clark, 2020, Blood advances.

Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.

P. Stephens, V. Miller, Siraj M. Ali, 2017, JCI insight.

Childhood pyelonephritis: Comparison of gadolinium-enhanced MR imaging and renal cortical scintigraphy for diagnosis

J. Morrison, T. Kao, G. Lonergan, 1998 .

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

Juan Wu, D. Weisdorf, B. Logan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.

S. Davies, C. Dandoy, A. Lane, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

EBV‐directed viral‐specific T‐lymphocyte therapy for the treatment of EBV‐driven lymphoma in two patients with primary immunodeficiency and DNA repair defects

P. Hanley, M. Absalon, C. Lutzko, 2019, Pediatric blood & cancer.

Allogeneic Human Mesenchymal Stem Cell Therapy (Prochymal®) As A Rescue Agent For Severe Treatment Resistant GVHD In Pediatric Patients

J. Kurtzberg, V. Prasad, S. Prockop, 2010 .

A Phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL)

S. Grupp, K. Boucher, M. Pulsipher, 2009, British journal of haematology.

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

K. Myers, S. Davies, P. Mehta, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.

S. Davies, M. Jordan, Ashish R. Kumar, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.

K. Trinkaus, M. Pulsipher, J. Bednarski, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Ranjit S. Chima, J. Khoury, K. Myers, 2014, Blood.

Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.

G. Cuvelier, M. Andreánsky, M. Bhatia, 2021, Transplantation and cellular therapy.

Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial

D. Wall, M. Duval, C. Jubert, 2011, Bone Marrow Transplantation.

Early Results from a Phase 1/2 Study of Aru-1801 Gene Therapy for Sickle Cell Disease (SCD): Manufacturing Process Enhancements Improve Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant

S. Witting, P. Malik, C. Lutzko, 2020 .

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

J. B. Oliveira, R. Gelman, L. Notarangelo, 2015, The Journal of clinical investigation.

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

N. Callander, N. Flomenberg, J. Essell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

J. B. Oliveira, R. Gelman, L. Notarangelo, 2016, The Journal of clinical investigation.

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.

K. Myers, S. Davies, P. Mehta, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Limitations of HLH‐2004 criteria in distinguishing malignancy‐associated hemophagocytic lymphohistiocytosis

M. Absalon, R. Lorsbach, M. Jordan, 2018, Pediatric blood & cancer.

Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial

G. Papanicolaou, T. Brundage, V. Prasad, 2017 .

Tocilizumab for Treatment of Children and Young Adults With Severe Acute COVID-19: Experience at a Quaternary-care Children’s Hospital

Joshua D. Courter, Ranjit S. Chima, R. Frenck, 2022, The Pediatric infectious disease journal.

Third party and patient-specific donor-derived virus-specific T cells demonstrate similar efficacy and safety for management of viral infections after hematopoietic stem cell transplant in children and young adults.

P. Hanley, C. Bollard, J. Cancelas, 2023, Transplantation and cellular therapy.

Ibrutinib for the treatment of chronic graft‐vs‐host disease in pediatric hematopoietic stem cell transplant patients: A single‐center experience

S. Davies, C. Dandoy, P. Khandelwal, 2020, Pediatric transplantation.

A case of treatment‐resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab

P. Khandelwal, M. Grimley, S. Benoit, 2022, Pediatric transplantation.

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant

P. Hanley, C. Bollard, J. Cancelas, 2022, Blood advances.

Prevalence of Viral Infections in Children Undergoing First Allogenic Hematopoietic Stem Cell Transplantation: Two Year Single Center Experience

K. Myers, S. Davies, P. Mehta, 2012 .

Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC)

K. Myers, S. Davies, J. Howell, 2021, Pediatric transplantation.

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

M. Norkin, M. Pasquini, S. Choi, 2017 .

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

A. Vinks, Kana Mizuno, K. Myers, 2015 .

Team‐based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients

Ranjit S. Chima, K. Myers, S. Davies, 2017, Pediatric blood & cancer.

Secondary Hemophagocytic Lymphohistiocytosis (HLH) from a Presumed Brown Recluse Spider Bite

C. Dandoy, M. Grimley, 2014, Journal of Clinical Immunology.

Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation.

M. Ardura, A. Seif, K. Bittinger, 2021, Pediatric blood & cancer.

Early microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation

M. Ardura, A. Seif, K. Bittinger, 2021, medRxiv.

Abstracts From the 32nd Annual Meeting of the Histiocyte Society Dublin, Ireland October 17-19, 2016.

Pooja, Wright, Tracey, 2016, Pediatric Blood & Cancer.

Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

T. Brundage, V. Prasad, H. Momméja-Marin, 2015 .

Frequency and magnitude of dose adjustment of IV busulfan in targeted dosing strategy for pediatric allogeneic transplantation

D. Wall, M. Grimley, Candace Taylor, 2004 .

Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients with Asymptomatic Adenovirus Viremia

J. Kurtzberg, T. Brundage, V. Prasad, 2014 .

Abatacept Decreases the Rate of Acute and Chronic Gvhd in Children with Sickle Cell Disease Undergoing Matched Sibling Transplants

S. Davies, P. Khandelwal, M. Grimley, 2020 .

T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

M. Norkin, M. Pasquini, M. Tighiouart, 2019, Biology of Blood and Marrow Transplantation.

Pediatric Phase II Study of Maraviroc for Acute Graft Versus Host Disease Prophylaxis

A. Vinks, K. Myers, S. Davies, 2019, Biology of Blood and Marrow Transplantation.

Viral‐specific T cells for Cytomegalovirus retinitis following hematopoietic stem cell transplantation: A success story

Suzanne M. Michalak, A. Bertaina, Ami J. Shah, 2023, Pediatric blood & cancer.

Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients.

S. Davies, L. Danziger-Isakov, Ashley Teusink‐Cross, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

D. Neuberg, S. Choi, B. Blazar, 2023, Blood.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

A. Schulz, W. Friedrich, A. Gennery, 2012, Blood.

Secondary Hemophagocytic Lymphohistiocytosis (HLH) from a Presumed Brown Recluse Spider Bite

C. Dandoy, M. Grimley, 2014, Journal of Clinical Immunology.

Eukaryotic Initiation Factor 4E Staining as a Clinical Marker in Pediatric Neuroblastoma

M. Grimley, D. Sorrells, A. Parker, 2004, Journal of pediatric hematology/oncology.

Adolescents and Young Adults With Hemophagocytic Lymphohistiocytosis Who Undergo Allogeneic Hematopoietic Cell Transplantation Are At Increased Risk Of Mortality Compared To Younger Patients

A. Filipovich, M. Jordan, S. Chandrakasan, 2013 .

Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience

S. Davies, A. Filipovich, M. Jordan, 2013 .

Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders

C. Dandoy, M. Grimley, J. Picarsic, 2023, Haematologica.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

J. Bolaños-Meade, Juan Wu, D. Weisdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single Site Experience of the use of Monoclonal Antibodies for the Treatment of COVID-19 in High-risk Pediatric and Young Adult Patients

Joshua D. Courter, R. Frenck, P. Spearman, 2022, The Pediatric infectious disease journal.

Novel Treatment of Infant With COVID-19 With the Sialidase Fusion Protein, DAS181.

R. Frenck, P. Spearman, L. Danziger-Isakov, 2021, The Pediatric infectious disease journal.

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

K. Myers, S. Davies, S. Jodele, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation.

Jeremy D. Rubinstein, M. Grimley, Thomas Pfeiffer, 2024, Journal of the Pediatric Infectious Diseases Society.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

J. B. Oliveira, R. Gelman, L. Notarangelo, 2016, The Journal of clinical investigation.

cmx001 is a potential treatment for Adenovirus infection: preliminary antiviral activity results from an open-label, expanded access study of Cmx001 for the treatment of serious or life-threatening diseases caused by doublestranded Dna viruses : o368

G. Papanicolaou, D. Margolskee, T. Brundage, 2013 .

Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients

M. Ardura, N. Halasa, L. Danziger-Isakov, 2024, Blood advances.

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

A. Rademaker, L. Lehmann, K. Schultz, 2009, Blood.